Skip to main content

Published locations for Ibrutinib-venetoclax produces high MRD-negative rates in CLL/SLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib-venetoclax produces high MRD-negative rates in CLL/SLL

User login

  • Reset your password
  • /content/ibrutinib-venetoclax-produces-high-mrd-negative-rates-cll/sll
  • /hematologynews/article/224293/cll/ibrutinib-venetoclax-produces-high-mrd-negative-rates-cll/sll
  • /oncologypractice/article/224293/cll/ibrutinib-venetoclax-produces-high-mrd-negative-rates-cll/sll
  • /hematology-oncology/article/224293/cll/ibrutinib-venetoclax-produces-high-mrd-negative-rates-cll/sll
  • /b-cell-lymphoma-icymi/article/224293/cll/ibrutinib-venetoclax-produces-high-mrd-negative-rates-cll